1. Infectious Disease Society of America (2004) Bad bugs, no drugs: as antibiotic discovery stagnates… a public health crisis brews. pp. 1–35 http://www.fda.gov/ohrms/dockets/dockets/04s0233/04s-0233-c000005-03-IDSA-vol1.pdf
2. ScienceDaily (2010) Mining bacterial genome reveals valuable “hidden” drugs. Aug. 2. http://www.sciencedaily.com/releases/2010/08/100801201329.htm
3. CDC (2012) CDC reminds clinical laboratories and healthcare infection preventionists of their role in the search and containment of vancomycin-resistant Staphylococcus aureus (VRSA). http://www.cdc.gov/HAI/settings/lab/vrsa_lab_search_containment.html
4. Baltz RH (2008) Renaissance in antibacterial discovery from actinomycetes. Curr Opin Pharmacol 8:557–563
5. Bergmann S, Shümann J, Scherlach K, Lange C, Brakhage AA, Hertweck C (2007) Genomics-driven discovery of PKS-NPRS hybrid metabolites from Aspergillus nidulans. Nat Chem Biol 3:213–217